IRCT20150808023559N20招募中1 期
Evaluation of safety and efficacy of hydroxychloroquine plus favipiravir drug regimen in comparison with hydroxychloroquine plus kaletra in hospitalized patients with COVID-19
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 16 years 至 100 years（—）
- 性别
- All
入选标准
- •Diagnosis of COVID-19 based on either ground glass appearance in chest CT scan or positive RT-PCR test for COVID-19
- •Requiring hospitalization
- •Patient's age between 16 and 100 years
- •Signed informed consent form
排除标准
- •Receiving other antiviral medications
- •renal failure
研究者
相似试验
已完成
3 期
Comparison of the safety and efficacy of Favipiravir and kaletra in COVID-19IRCT20200318046812N1Iran University of Medical Sciences324
招募中
4 期
A Clinical Trial to Study the Safety and Efficacy of Hydroxychloroquine in Patients with Type-2 DaibetesCTRI/2016/02/006599Ipca Laboratories Ltd600
招募中
3 期
Treatment of Hydroxychloroquine in Type 2 Diabetes Patients Uncontrolled on Metformin MonotherapyCTRI/2021/11/037750Ipca Laboratories Ltd
招募中
3 期
Evaluation the effects of Hydroxychloroquine administration for COVID-19 prophylaxisCOVID-19 pneumonia.COVID-19, virus not identifiedU07.2IRCT20130917014693N10Shahid Beheshti University of Medical Sciences100
招募中
2 期
Combination therapy in COVID 19COVID-19 pneumonia.IRCT20100228003449N30Tehran University of Medical Sciences50